GSS — Genetic Signatures Income Statement
0.000.00%
Last trade - 00:00- AU$90.86m
- AU$51.08m
- AU$14.27m
- 69
- 32
- 31
- 41
Annual income statement for Genetic Signatures, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 14.2 | 28.7 | 35.6 | 22.1 | 14.3 |
| Cost of Revenue | |||||
| Gross Profit | 8.1 | 17.5 | 22 | 10.2 | 6.36 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 16.1 | 26.9 | 32.5 | 36 | 32 |
| Operating Profit | -1.92 | 1.86 | 3.17 | -13.9 | -17.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -2.09 | 1.76 | 3.06 | -14.1 | -17.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.09 | 1.76 | 3.06 | -14.1 | -17.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.09 | 1.76 | 3.06 | -14.1 | -17.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -2.09 | 1.76 | 3.06 | -14.1 | -17.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.016 | 0.012 | 0.021 | -0.096 | -0.108 |
| Dividends per Share |